Literature DB >> 6356119

The treatment of irritable bowel syndrome. Two doses of mebeverine compared.

B J Prout.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356119

Source DB:  PubMed          Journal:  Practitioner        ISSN: 0032-6518


× No keyword cloud information.
  5 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.

Authors:  G Dobrilla; B P Imbimbo; L Piazzi; G Bensi
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 3.  A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.

Authors:  Mahnaz Darvish-Damavandi; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

Review 4.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

Review 5.  The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome-A Systematic Review.

Authors:  Jaroslaw Daniluk; Ewa Malecka-Wojciesko; Barbara Skrzydlo-Radomanska; Grazyna Rydzewska
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.